"Top Ten Application Scenarios for the Integration of π-HuB Plan and Biomanufacturing Industry" was released in Guangzhou

China News Service, Guangzhou, September 25 (Reporter Wang Jian) ​​According to news from the Guangdong Smart Medicine International Research Institute on the 25th, the "Top Ten Application Scenarios for the Integration of the π-HuB Plan and the Biomanufacturing Industry" (hereinafter referred to as the "Top Ten Scenarios") was officially released recently. The top ten scenarios provide replicable implementation paths for the upgrading and upgrading of the biomanufacturing industry.

According to the Guangdong Smart Medicine International Research Institute, the ten scenarios were designed by the institute and condensed together with the Shenzhen Institute of Advanced Technology and other relevant parties, covering the proteomic navigation and high-throughput directional domestication of industrial strains, enzyme engineering and strain metabolic transformation to collaboratively empower green biomanufacturing, and the proteomics diagnostic system of cell factories.

In addition, at the 2nd π-HuB Industry Conference and Synthetic Biology Manufacturing Industry Conference, the "Smart Medicine Joint Research Center (Changde)" jointly built by Guangdong Smart Medicine International Research Institute and Changde First People's Hospital was officially unveiled. This joint research center is an important layout for the clinical operation center of the π-HuB plan to extensively connect large-scale clinical cohorts with special features and clinical medical research teams, aiming to promote the real implementation of proteomics-driven precision medicine (PDPM).

Currently, both parties have launched proteomics research on oral cancer (tongue cancer), a local characteristic cancer based on the center. The joint research center will rely on the π-HuB international cooperation network to bring together top oral cancer clinical research teams at home and abroad to focus on early screening and accurate diagnosis and treatment of this cancer, forming a closed loop of "clinical problem traction - proteomics verification - diagnostic and treatment product transformation".

Zheng Yuzi, deputy director of the Guangdong Smart Medicine International Research Institute, the international executive headquarters of the π-HuB plan, said that the value of the big science plan ultimately lies in industrial transformation. The π-HuB plan supports predictions based on the principles of human body composition and guides design with a life navigation system to provide source supply for new productivity. In the future, the π-HuB industry will continue to use big science plans as demand-driven and industrial funds + industrial parks as carriers. It will be based in Guangzhou and take root in the Bay Area, accelerating the construction of a closed-loop flywheel from original discovery, technology incubation, industrial implementation to market value.